Kakeromycin Synthesis for Low-Molecular-Weight Antifungals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antifungal agents have high toxicity and large molecular weights, leading to reactivity issues with serum, while azole-based agents face challenges with high concentration administration due to toxicity, necessitating a low-molecular-weight compound with low serum reactivity and toxicity for effective antifungal and anticancer applications.
Innovation Solution
A method for producing kakeromycin and its derivatives through chemical synthesis, involving steps such as oxidation reactions, intramolecular dehydration condensation, and cyclization addition reactions, to yield compounds with antifungal and cytotoxic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antifungal agents (candin-based) are used, then antifungal activity is achieved, but molecular weight is large causing reactivity problems with serum
Solution Approach 1:
The patent changes the molecular weight parameter by synthesizing kakeromycin with a molecular weight of 246.3 g/mol, which is significantly lower than conventional candin-based antifungals. This parameter change resolves the contradiction by maintaining antifungal activity while reducing molecular weight to eliminate serum reactivity problems.
2Reliability
If azole-based antifungal agents are used, then antifungal activity is achieved, but toxicity increases making high concentration administration difficult
Solution Approach 1:
The patent employs a novel chemical structure (bicyclic oxaziridine core with specific substituent pattern) that provides high antifungal activity through a different mechanism than conventional azoles. The synthetic approach allows optimization of the molecule to achieve high efficacy at low concentrations, avoiding the toxicity issue associated with high-dose azole administration.
3Adaptability or versatility
If microbial metabolites are searched for new medicaments, then novel compounds are obtained, but continuous search over long term yields mostly known compounds with extremely difficult to obtain new candidates
Solution Approach 1:
The patent replaces the traditional biological search method (harvesting and separating microbial metabolites from land areas) with a chemical synthesis approach. By using chemical synthesis, the invention can efficiently produce novel compounds with specific biological activities without the time-consuming natural product search process, thus resolving the contradiction between obtaining novel compounds and the time required for search.
4Productivity
If chemical library screening is conducted, then global scale search is performed, but promising novel medicament candidate compounds are not obtained
Solution Approach 1:
The patent uses a targeted chemical synthesis approach with a specific reaction pathway (starting from commercially available materials and proceeding through defined intermediate steps) to directly obtain novel compounds with desired properties. This intermediary synthesis method is more efficient than broad chemical library screening and guarantees the obtention of novel compounds with specific biological activities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chemical synthesis method enables the production of kakeromycin and its derivatives, which exhibit strong antifungal activity and cytotoxicity, making them potential new antifungal and anticancer agents with improved safety profiles.
Implementation Method 1
which comprises a step of subjecting a compound represented by the formula (2) to an oxidation reaction
Implementation Method 2
further comprising a step of producing a compound represented by the formula (2) by subjecting a compound represented by the formula (3) to an intramolecular dehydration condensation reaction
Implementation Method 3
further comprising a step of producing a compound represented by the formula (3) by subjecting a compound represented by the formula (4) to a cyclization addition reaction
Data Source
AI summary
Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1):wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2):wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.